Kim Forest Kim Forest (金萬林企業股份有限公司) is a company that develops, manufactures, and sells biomedical products. | ![]() Lutonix Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation. | ![]() Intra-Cellular Therapies Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS. | ![]() Histocell Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine. | |
Founding Date | Founding Date 2004 | Founding Date 2007 | Founding Date 2002 | Founding Date 2011 |
Type | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | ||||
Locations | Locations HQ | Locations Maple Grove, US HQ | Locations New York, US HQ | Locations Derio, ES HQ Larrabetzu, ES |
Employees | Employees N/A | Employees 10 | Employees 330352% increase | Employees 365% decrease |
Financial | ||||
Revenue (est.) | Revenue (est.) NT$549.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $680.9m (FY, 2024) | Revenue (est.) N/A |
Net income | Net income (NT$148m) (FY, 2025) | Net income N/A | Net income ($74.7m) (FY, 2024) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 35m | Total funding raised $ 225.3m | Total funding raised N/A |

Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation.
View company
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.
View company
Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine.
View company